Prava policitemija (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prava policitemija" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

22nih.gov

4^th place

8^th place

14doi.org

2^nd place

5^th place

6semanticscholar.org

11^th place

51^st place

5archive.org

6^th place

9^th place

1termania.net

low place

34^th place

1britannica.com

40^th place

16^th place

1mayoclinic.com

3,634^th place

1,010^th place

1medscape.com

719^th place

152^nd place

1hematologyandoncology.net

low place

1mayoclinic.org

1,610^th place

418^th place

1europa.eu

68^th place

28^th place

1fda.gov

447^th place

409^th place

1businesswire.com

615^th place

3,307^th place

archive.org

Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). »Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge«. Br J Dermatol. 116 (3): 329–333. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). »Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus«. Br J Dermatol. 116 (1): 21–29. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). »Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori«. Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). »Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera«. Semin Thromb Hemost. 23 (4): 357–363. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). »Erythromelalgia and vascular complications in polycythemia vera«. Semin Thromb Hemost. 23 (5): 441–454. doi:10.1055/s-2007-996121. PMID 9387203.

britannica.com

"polycythemia vera." at Encyclopædia Britannica. 2010. Encyclopædia Britannica Online. 21 sept. 2010

businesswire.com

»U.S. FDA Approves Besremi (ropeginterferon alfa-2b-njft) as the Only Interferon for Adults With Polycythemia Vera« (tiskovna objava). PharmaEssentia. 12. november 2021. Pridobljeno 14. novembra 2021 – prek Business Wire.

doi.org

Saini KS, Patnaik MM, Tefferi A (2010). »Polycythemia vera-associated pruritus and its management«. Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). »Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge«. Br J Dermatol. 116 (3): 329–333. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). »Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus«. Br J Dermatol. 116 (1): 21–29. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). »Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement«. Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512. PMID 94209. S2CID 6909368.
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). »Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori«. Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). »Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera«. Semin Thromb Hemost. 23 (4): 357–363. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). »Erythromelalgia and vascular complications in polycythemia vera«. Semin Thromb Hemost. 23 (5): 441–454. doi:10.1055/s-2007-996121. PMID 9387203.
Landolfi R, Ciabattoni G, Patrignani P, Castellana M, Pogliani E, Bizzi B, Patrono C (1992). »Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo«. Blood. 80 (8): 1965–1971. doi:10.1182/blood.V80.8.1965.1965. PMID 1327286.
Streiff MB, Smith B, Spivak JL (2002). »The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns«. Blood. 99 (4): 1144–1149. doi:10.1182/blood.V99.4.1144. PMID 11830459.
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). »Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit«. Eur. Neurol. 44 (1): 57–59. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Björkholm, M; Derolf, AR; Hultcrantz, M; in sod. (10. junij 2011). »Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms«. Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). »Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth«. J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (10. januar 2018). »Polycythemia vera treatment algorithm 2018«. Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). »Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989«. Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.

europa.eu

ema.europa.eu

»Besremi EPAR«. Evropska agencija za zdravila (EMA). 12. december 2018. Pridobljeno 14. novembra 2021.

fda.gov

»FDA Approves Treatment for Rare Blood Disease«. U.S. Food and Drug Administration (FDA) (tiskovna objava). 12. november 2021. Pridobljeno 12. novembra 2021. Članek vsebuje besedilo iz tega vira, ki je v javni domeni.

hematologyandoncology.net

Verstovsek, S. (2016). »Highlights in polycythemia vera from the 2016 EHA congress«. Clin Adv Hematol Oncol. 14 (10): 810–813. PMID 27930632.{{navedi časopis}}: Vzdrževanje CS1: uporablja parameter authors (povezava)

mayoclinic.com

Mayo Clinic staff. »Polycythemia vera - MayoClinic.com«. Polycythemia vera: Definition. Mayo Clinic. Pridobljeno 3. septembra 2011.

mayoclinic.org

»Polycythemia vera - Diagnosis and treatment - Mayo Clinic«. www.mayoclinic.org (v angleščini). Pridobljeno 11. marca 2022.

medscape.com

emedicine.medscape.com

»Polycythemia Vera Follow-up«. Pridobljeno 3. septembra 2011.

nih.gov

pubmed.ncbi.nlm.nih.gov

Saini KS, Patnaik MM, Tefferi A (2010). »Polycythemia vera-associated pruritus and its management«. Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). »Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge«. Br J Dermatol. 116 (3): 329–333. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). »Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus«. Br J Dermatol. 116 (1): 21–29. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). »Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement«. Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512. PMID 94209. S2CID 6909368.
Berlin NI (1975). »Diagnosis and classification of polycythemias«. Semin Hematol. 12 (4): 339–351. PMID 1198126.
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). »Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori«. Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). »Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera«. Semin Thromb Hemost. 23 (4): 357–363. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). »Erythromelalgia and vascular complications in polycythemia vera«. Semin Thromb Hemost. 23 (5): 441–454. doi:10.1055/s-2007-996121. PMID 9387203.
Landolfi R, Ciabattoni G, Patrignani P, Castellana M, Pogliani E, Bizzi B, Patrono C (1992). »Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo«. Blood. 80 (8): 1965–1971. doi:10.1182/blood.V80.8.1965.1965. PMID 1327286.
Streiff MB, Smith B, Spivak JL (2002). »The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns«. Blood. 99 (4): 1144–1149. doi:10.1182/blood.V99.4.1144. PMID 11830459.
Verstovsek, S. (2016). »Highlights in polycythemia vera from the 2016 EHA congress«. Clin Adv Hematol Oncol. 14 (10): 810–813. PMID 27930632.{{navedi časopis}}: Vzdrževanje CS1: uporablja parameter authors (povezava)
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). »Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit«. Eur. Neurol. 44 (1): 57–59. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Björkholm, M; Derolf, AR; Hultcrantz, M; in sod. (10. junij 2011). »Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms«. Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). »Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth«. J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (10. januar 2018). »Polycythemia vera treatment algorithm 2018«. Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.
Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M (2003). »Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia«. Haematologica. 88 (1): 13–18. PMID 12551821.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). »Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989«. Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.

ncbi.nlm.nih.gov

Lu, Xiao; Chang, Richard (24. april 2023). »Polycythemia Vera«. StatPearls Publishing LLC. Pridobljeno 28. julija 2023.
Björkholm, M; Derolf, AR; Hultcrantz, M; in sod. (10. junij 2011). »Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms«. Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). »Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth«. J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (10. januar 2018). »Polycythemia vera treatment algorithm 2018«. Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.

nhlbi.nih.gov

»What Is Polycythemia Vera?«. National Heart, Lung and Blood Institute. Pridobljeno 3. septembra 2011.

semanticscholar.org

api.semanticscholar.org

Saini KS, Patnaik MM, Tefferi A (2010). »Polycythemia vera-associated pruritus and its management«. Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). »Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge«. Br J Dermatol. 116 (3): 329–333. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). »Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus«. Br J Dermatol. 116 (1): 21–29. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). »Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement«. Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512. PMID 94209. S2CID 6909368.
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). »Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit«. Eur. Neurol. 44 (1): 57–59. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). »Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989«. Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5533554/policitemija?query=policitemija&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 27. 7. 2023.